Global Guillain-Barré Syndrome Market Research Report 2019
Table of Contents
Executive Summary
1 Guillain-Barré Syndrome Market Overview
- 1.1 Product Overview and Scope of Guillain-Barré Syndrome
- 1.2 Guillain-Barré Syndrome Segment by Type
- 1.2.1 Global Guillain-Barré Syndrome Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Intravenous Immunoglobulin
- 1.2.3 Plasma Exchange
- 1.2.4 Others (Analgesics, Anticonvulsants, LMWH, etc.)
- 1.3 Guillain-Barré Syndrome Segment by Application
- 1.3.1 Guillain-Barré Syndrome Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospital Pharmacies
- 1.3.3 Retail Pharmacies
- 1.3.4 Others (Home Care, Clinics, etc.)
- 1.3 Global Guillain-Barré Syndrome Market by Region
- 1.3.1 Global Guillain-Barré Syndrome Market Size Region
- 1.3.2 North America Status and Prospect (2014-2025)
- 1.3.3 Europe Status and Prospect (2014-2025)
- 1.3.4 China Status and Prospect (2014-2025)
- 1.3.5 Japan Status and Prospect (2014-2025)
- 1.3.6 Southeast Asia Status and Prospect (2014-2025)
- 1.3.7 India Status and Prospect (2014-2025)
- 1.4 Global Guillain-Barré Syndrome Market Size
- 1.4.1 Global Guillain-Barré Syndrome Revenue (2014-2025)
- 1.4.2 Global Guillain-Barré Syndrome Production (2014-2025)
2 Global Guillain-Barré Syndrome Market Competition by Manufacturers
- 2.1 Global Guillain-Barré Syndrome Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Guillain-Barré Syndrome Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Guillain-Barré Syndrome Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Guillain-Barré Syndrome Production Sites, Area Served, Product Types
- 2.5 Guillain-Barré Syndrome Market Competitive Situation and Trends
- 2.5.1 Guillain-Barré Syndrome Market Concentration Rate
- 2.5.2 Guillain-Barré Syndrome Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Guillain-Barré Syndrome Production Market Share by Regions
- 3.1 Global Guillain-Barré Syndrome Production Market Share by Regions
- 3.2 Global Guillain-Barré Syndrome Revenue Market Share by Regions (2014-2019)
- 3.3 Global Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Guillain-Barré Syndrome Production
- 3.4.1 North America Guillain-Barré Syndrome Production Growth Rate (2014-2019)
- 3.4.2 North America Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Guillain-Barré Syndrome Production
- 3.5.1 Europe Guillain-Barré Syndrome Production Growth Rate (2014-2019)
- 3.5.2 Europe Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Guillain-Barré Syndrome Production (2014-2019)
- 3.6.1 China Guillain-Barré Syndrome Production Growth Rate (2014-2019)
- 3.6.2 China Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Guillain-Barré Syndrome Production (2014-2019)
- 3.7.1 Japan Guillain-Barré Syndrome Production Growth Rate (2014-2019)
- 3.7.2 Japan Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Guillain-Barré Syndrome Consumption by Regions
- 4.1 Global Guillain-Barré Syndrome Consumption by Regions
- 4.2 North America Guillain-Barré Syndrome Consumption (2014-2019)
- 4.3 Europe Guillain-Barré Syndrome Consumption (2014-2019)
- 4.4 China Guillain-Barré Syndrome Consumption (2014-2019)
- 4.5 Japan Guillain-Barré Syndrome Consumption (2014-2019)
5 Global Guillain-Barré Syndrome Production, Revenue, Price Trend by Type
- 5.1 Global Guillain-Barré Syndrome Production Market Share by Type (2014-2019)
- 5.2 Global Guillain-Barré Syndrome Revenue Market Share by Type (2014-2019)
- 5.3 Global Guillain-Barré Syndrome Price by Type (2014-2019)
- 5.4 Global Guillain-Barré Syndrome Production Growth by Type (2014-2019)
6 Global Guillain-Barré Syndrome Market Analysis by Applications
- 6.1 Global Guillain-Barré Syndrome Consumption Market Share by Application (2014-2019)
- 6.2 Global Guillain-Barré Syndrome Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Guillain-Barré Syndrome Business
- 7.1 Grifols
- 7.1.1 Grifols Guillain-Barré Syndrome Production Sites and Area Served
- 7.1.2 Guillain-Barré Syndrome Product Introduction, Application and Specification
- 7.1.3 Grifols Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 CSL Behring
- 7.2.1 CSL Behring Guillain-Barré Syndrome Production Sites and Area Served
- 7.2.2 Guillain-Barré Syndrome Product Introduction, Application and Specification
- 7.2.3 CSL Behring Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Shire
- 7.3.1 Shire Guillain-Barré Syndrome Production Sites and Area Served
- 7.3.2 Guillain-Barré Syndrome Product Introduction, Application and Specification
- 7.3.3 Shire Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Octapharma
- 7.4.1 Octapharma Guillain-Barré Syndrome Production Sites and Area Served
- 7.4.2 Guillain-Barré Syndrome Product Introduction, Application and Specification
- 7.4.3 Octapharma Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Nihon Pharmaceutical
- 7.5.1 Nihon Pharmaceutical Guillain-Barré Syndrome Production Sites and Area Served
- 7.5.2 Guillain-Barré Syndrome Product Introduction, Application and Specification
- 7.5.3 Nihon Pharmaceutical Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Akari Therapeutics
- 7.6.1 Akari Therapeutics Guillain-Barré Syndrome Production Sites and Area Served
- 7.6.2 Guillain-Barré Syndrome Product Introduction, Application and Specification
- 7.6.3 Akari Therapeutics Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 China Biologic Products Holdings
- 7.7.1 China Biologic Products Holdings Guillain-Barré Syndrome Production Sites and Area Served
- 7.7.2 Guillain-Barré Syndrome Product Introduction, Application and Specification
- 7.7.3 China Biologic Products Holdings Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Biotest
- 7.8.1 Biotest Guillain-Barré Syndrome Production Sites and Area Served
- 7.8.2 Guillain-Barré Syndrome Product Introduction, Application and Specification
- 7.8.3 Biotest Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Kedrion s.p.A.
- 7.9.1 Kedrion s.p.A. Guillain-Barré Syndrome Production Sites and Area Served
- 7.9.2 Guillain-Barré Syndrome Product Introduction, Application and Specification
- 7.9.3 Kedrion s.p.A. Guillain-Barré Syndrome Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
8 Guillain-Barré Syndrome Manufacturing Cost Analysis
- 8.1 Guillain-Barré Syndrome Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Guillain-Barré Syndrome
- 8.4 Guillain-Barré Syndrome Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Guillain-Barré Syndrome Distributors List
- 9.3 Guillain-Barré Syndrome Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Guillain-Barré Syndrome Market Forecast
- 11.1 Global Guillain-Barré Syndrome Production, Revenue Forecast
- 11.1.1 Global Guillain-Barré Syndrome Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Guillain-Barré Syndrome Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Guillain-Barré Syndrome Price and Trend Forecast (2019-2025)
- 11.2 Global Guillain-Barré Syndrome Production Forecast by Regions (2019-2025)
- 11.2.1 North America Guillain-Barré Syndrome Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Guillain-Barré Syndrome Production, Revenue Forecast (2019-2025)
- 11.2.3 China Guillain-Barré Syndrome Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Guillain-Barré Syndrome Production, Revenue Forecast (2019-2025)
- 11.3 Global Guillain-Barré Syndrome Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Guillain-Barré Syndrome Consumption Forecast (2019-2025)
- 11.3.2 Europe Guillain-Barré Syndrome Consumption Forecast (2019-2025)
- 11.3.3 China Guillain-Barré Syndrome Consumption Forecast (2019-2025)
- 11.3.4 Japan Guillain-Barré Syndrome Consumption Forecast (2019-2025)
- 11.4 Global Guillain-Barré Syndrome Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Guillain-Barré Syndrome Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The global Guillain-Barré Syndrome market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Guillain-Barré Syndrome volume and value at global level, regional level and company level. From a global perspective, this report represents overall Guillain-Barré Syndrome market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Grifols
CSL Behring
Shire
Octapharma
Nihon Pharmaceutical
Akari Therapeutics
China Biologic Products Holdings
Biotest
Kedrion s.p.A.
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Intravenous Immunoglobulin
Plasma Exchange
Others (Analgesics, Anticonvulsants, LMWH, etc.)
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others (Home Care, Clinics, etc.)